SCHEMBL9644530

SCHEMBL9644530

CCOC(=O)NN=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10663041 0.78
SCHEMBL16870404 0.78
SCHEMBL14492119 0.78
SCHEMBL4659997 0.76 RAB9A (0.49)
SCHEMBL16977362 0.76
SCHEMBL3522854 0.75 RAB9A (0.47)
SCHEMBL3522852 0.75 RAB9A (0.47)
SCHEMBL11427472 0.75 GAA (0.43)
SCHEMBL28349630 0.75 ALOX15 (0.46)
SCHEMBL14196325 0.75

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-105658604-B Among organic compound or it is related to the improvement of organic compound 奇华顿股份有限公司 2019-10-25 CN disclosed
US-5086052-A Antiarthritic, antiallergens, antiinflammatory agents; also for asthma and psoriasis ABBOTT LABORATORIES (US) 1992-02-04 US disclosed
US-4970210-A ENZYME INHIBITORS ABBOTT LABORATORIES (US) 1990-11-13 US disclosed
EP-0299449-A2 Pyridazinone, triazinone and oxapyridazinone lipoxygenase inhibiting compounds ABBOTT LABORATORIES (US) 1989-01-18 EP disclosed